Since the HIF-1α targets, VEGF-A and VEGF-C, are involved in tumor angiogenesis and lymphangiogenesis, we further assessed the effects of everolimus on potential crosstalk between tumor and vascular endothelial and lymphatic cells. This evidence concerns the gene VEGFA and neoplasm.